Psychoeducation (PE)

Psychoeducation (PE) provides patients with information about their conditions, including causes, disorder course, treatment options, methods to help detect and prevent relapse, and coping strategies.1 PE may help reduce the self-stigma that patients with a mental illness perceive and challenge the stigma exhibited by society.2,3 Inclusion of family members in PE may help improve the quality of life for the patient and their family, and it may also improve family function.4,5 PE typically consists of 6 to 21 structured sessions and can be used alone or in conjunction with other psychotherapies.1
Description: Psychoeducation (PE) provides patients with information about their conditions, including causes, disorder course, treatment options, methods to help detect and prevent relapse, and coping strategies.1 PE may help reduce the self-stigma that patients with a mental illness perceive and challenge the stigma exhibited by society.2,3 Inclusion of family members in PE may help improve the quality of life for the patient and their family, and it may also improve family function.4,5 PE typically consists of 6 to 21 structured sessions and can be used alone or in conjunction with other psychotherapies.1
Potentially effective for the following mental health concerns: Bipolar disorder, Depressive disorders, Substance-use disorders
Potentially effective in the following age groups: Adult
Treatment setting options: Individual, Group, Family
Treatment format options: In-person
Typical treatment duration: < 10 sessions, 10-20 sessions, 20+ sessions, Variable
Potential limitations: It may not be as effective as more intensive psychotherapies such as functional remediation or cognitive behavioral therapy.1

Footnotes:

Supporting references for the filters are as follows:

Potentially effective for the following mental health concerns: Bipolar disorder,1 Depressive disorders,6 Substance-use disorders7; Potentially effective in the following age groups: Adult1; Treatment setting options: Individual,1 Group,1 Family4,5; Treatment format options: In-person4; Typical treatment duration: < 10 sessions,1 10–20 sessions,1 20+ sessions,1 Variable1
 

This resource is intended for educational purposes only and is intended for US healthcare professionals. Healthcare professionals should use independent medical judgment. All decisions regarding patient care must be handled by a healthcare professional and be made based on the unique needs of each patient. 
 

ABBV-US-01698-MC, Version 1.0
Approved 07/2024
AbbVie Medical Affairs

References:

  1. Swartz HA, Swanson J. Psychotherapy for bipolar disorder in adults: a review of the evidence. Focus. 2014;12(3):251-266. doi:10.1176/appi.focus.12.3.251 
  2. Han DY, Chen SH. Reducing the stigma of depression through neurobiology-based psychoeducation: a randomized controlled trial. Psychiatry Clin Neurosci. 2014;68(9):666-673. doi:10.1111/pcn.12174 
  3. Ivezić SŠ, Sesar MA, Mužinić L. Effects of a group psychoeducation program on self-stigma, empowerment and perceived discrimination of persons with schizophrenia. Psychiatr Danub. 2017;29(1):66-73. 
  4. Ngoc TN, Weiss B, Trung LT. Effects of the family schizophrenia psychoeducation program for individuals with recent onset schizophrenia in Viet Nam. Asian J Psychiatr. 2016;22:162-166. doi:10.1016/j.ajp.2016.06.001 
  5. Katsuki F, Takeuchi H, Inagaki T, et al. Brief multifamily psychoeducation for family members of patients with chronic major depression: a randomized controlled trial. BMC Psychiatry. 2018;18(1):207. Published 2018 Jun 22. doi:10.1186/s12888-018-1788-6 
  6. Melin EO, Svensson R, Thulesius HO. Psychoeducation against depression, anxiety, alexithymia and fibromyalgia: a pilot study in primary care for patients on sick leave. Scand J Prim Health Care. 2018;36(2):123-133. doi:10.1080/02813432.2018.1459225 
  7. Ekhtiari H, Rezapour T, Aupperle RL, Paulus MP. Neuroscience-informed psychoeducation for addiction medicine: a neurocognitive perspective. Prog Brain Res. 2017;235:239-264. doi:10.1016/bs.pbr.2017.08.013 

Welcome To NP Psych Navigator

This website is intended for healthcare professionals inside the United States.
Please confirm that you are a healthcare professional inside the US.

No, I am not US Healthcare professional

You are now leaving NP Psych Navigator

Links to sites outside of NP Psych Navigator are provided as a resource to the viewer. AbbVie Inc accepts no responsibility for the content of non-AbbVie linked sites.

Redirect to:

Please to bookmark content